Drug Shortage Report for VIOKACE
| Report ID | 73777 |
| Drug Identification Number | 02230019 |
| Brand name | VIOKACE |
| Common or Proper name | Viokace |
| Company Name | NESTLE ENTERPRISES S.A. |
| Market Status | MARKETED |
| Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
| Strength(s) | 56400UNIT 57100UNIT 10440UNIT |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100's count bottle |
| ATC code | A09AA |
| ATC description | DIGESTIVES, INCL ENZYMES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-02-15 |
| Actual start date | |
| Estimated end date | 2019-04-19 |
| Actual end date | 2019-01-29 |
| Shortage status | Avoided shortage |
| Updated date | 2019-01-29 |
| Company comments | Delay with product release and raw material replenishment. Viokace 10440 will remain available to alleviate impact. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
| Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-01-29 | French | Compare |
| v3 | 2019-01-29 | English | Compare |
| v2 | 2019-01-29 | French | Compare |
| v1 | 2019-01-29 | English | Compare |
Showing 1 to 4 of 4